In the afternoon of March 8, Jia Chunsheng, vice president of Shandong Yinfeng Life Science Research Institute (our foundation research unit), Liu Zhicheng, general manager of Yinfengda Health Technology Service Co., Ltd., and Zang Chuanbao, director of Cryogenic Medical Research Center, were invited to attend the hospital-enterprise cooperation meeting held by the Orthopaedics Department of Qilu Hospital of Shandong University.
Recently, the cryogenic Medical Center of Shandong Yinfeng Life Science Research Institute (the research unit of our foundation) once again obtained the invention patent of "a kind of placental tissue matrix material and its preparation method". Up to now, the total number of patents granted by the cryogenic medical team in the State intellectual property Office has reached 25.
Large segmental bone defect is a common clinical disease. Stem cells and bone tissue engineering are considered to be a promising method of bone regeneration. Recently, Shandong Yinfeng Institute of Life Sciences and the team of Shandong University have studied a biomimetic construction of bioactive three-dimensional osteoid tissue on a nanocellulose membrane platform for stem cell multi-lineage differentiation, which can significantly promote the rapid growth of new bone and the rapid formation of capillaries and nerve fibers.
On January 11, 2021, Dr. CEO Alex Zhavoronkov of Deep Longevity Company and Hong Kong Insilico Medicine Company and Dr. Zhou Zhou of Shanghai Office visited Shandong Yinfeng Life Science Research Institute (our foundation's research unit) for a visit and exchange.
On the morning of October 17, 2020, the 12th National Annual Conference on Cryogenic Biomedicine and Devices was solemnly held in Jinan, Quancheng, with the theme of "low temperature helps healthy China" for two days. more than 100 cryogenic biomedical experts from all over the country attended the meeting.